We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Letter to the chair of the ACMD asking the council to conduct an updated assessment of the health and social harms of nitrous oxide.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
First published during the 2022 to 2024 Sunak Conservative government
The government’s response to the ACMD’s fentanyl report.
First published during the 2019 to 2022 Johnson Conservative government
Report from the Advisory Council on the Misuse of Drugs (ACMD) on the classification and schedule of Remimazolam.
Letter to the chair of the ACMD inviting them to establish a working group to respond to the recent white paper on drug possession.
First published during the 2022 Truss Conservative government
Letter from ACMD to ministers, providing advice on the administration rights of morphine by injection for therapeutic radiographer independent prescribers.
Letter from Advisory Council on the Misuse of Drugs (ACMD) to ministers, providing advice on independent prescribing of controlled drugs by paramedics.
Government response to the ACMD's advice on the prescribing of controlled drugs by paramedics and on the administration rights of morphine by injection for therapeutic radiographers.
The Advisory Council on the Misuse of Drugs (ACMD) has published a report reviewing the availability and use of naloxone in the UK, a drug used to reverse opioid overdose.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on the interim podiatrists supply proposal.
The report "Preventing drug use among vulnerable groups of people", commissioned by the Home Office, has been published by the ACMD.
The government commissions the ACMD to advise on the appropriate classification and scheduling of Isotonitazene and related compounds.
The government responds to the ACMD reports on cannabis-based products for medicinal use (CBPMs) in humans.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on Sunosi advice.
Barriers to Research working group calls for written evidence about barriers to legitimate research for controlled drugs, excluding synthetic cannabinoids.
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
The Advisory Council on the Misuse of Drugs (ACMD) has reappointed 4 experts in their fields to serve their third term on the council.
A review of the evidence of use and harms of novel benzodiazepines.
Three new members of the Advisory Council for the Misuse of Drugs (ACMD) have been announced today.
ACMD public request for written evidence on cognition enhancers (also known as ‘nootropics’ or ‘study drugs’).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).